Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

NanoCrystal® Technology


Published on

It is estimated that in excess of 40% of compounds in development suffer from poor solubility, making them difficult to develop and resulting in a significant number of potentially beneficial compounds being discarded in development each year. EDT’s NanoCrystal® technology addresses this key problem for the pharmaceutical industry.

  • Be the first to comment